caffeic acid phenethyl ester has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdik, H; Avşar Abdik, E; Sahin, F; Turan, D | 1 |
| Balaha, M; Cataldi, A; De Filippis, B; di Giacomo, V | 1 |
1 review(s) available for caffeic acid phenethyl ester and Parkinson Disease
| Article | Year |
|---|---|
CAPE and Neuroprotection: A Review.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Antifungal Agents; Antioxidants; Antiviral Agents; Apoptosis; Brain; Caffeic Acids; Humans; Inflammation; Ischemia; Neurodegenerative Diseases; Parkinson Disease; Phenylethyl Alcohol; Propolis; Psychotic Disorders; Seizures | 2021 |
1 other study(ies) available for caffeic acid phenethyl ester and Parkinson Disease
| Article | Year |
|---|---|
Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
Topics: Antiparkinson Agents; Apoptosis; Apoptosis Regulatory Proteins; Caffeic Acids; Cell Line, Tumor; Humans; Membrane Potential, Mitochondrial; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Phenylethyl Alcohol; Reactive Oxygen Species; Signal Transduction | 2020 |